Real -world efficacy of switching to faricimab therapy in patients with longstanding neovascular age -related macular degeneration

被引：0
|
作者：
Long Phan [1 ,2 ]
Chin, Jennifer [1 ]
Hong, Thomas [1 ,2 ]
Chang, Andrew [1 ,2 ]
机构：
[1] CUREOS, Sydney, NSW, Australia
[2] Sydney Retina, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
234
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Real world utilization of intravitreal faricimab in patients with neovascular age -related macular degeneration
    Garcia, Brisa
    Wang, Angeline
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [2] Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab
    Hoshino, Junki
    Matsumoto, Hidetaka
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025, : 221 - 229
  • [3] Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration
    Eckardt, Franziska
    Lorger, Anna
    Hafner, Michael
    Klaas, Julian Elias
    Schworm, Benedikt
    Kreutzer, Thomas Christian
    Priglinger, Siegfried Georg
    Siedlecki, Jakob
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [5] Faricimab Combination Therapy for Sustained Efficacy in Neovascular Age-Related Macular Degeneration
    De La Huerta, Irina
    Kim, Stephen J.
    Sternberg, Paul, Jr.
    JAMA OPHTHALMOLOGY, 2020, 138 (09) : 972 - 973
  • [6] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [7] REAL WORLD EFFICACY AND DURABILITY OF FARICIMAB IN SUB-OPTIMAL RESPONDER PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Hernaez, Jimena Soto
    Goodchild, Christine
    Bailey, Clare
    Ahmed, Eslam
    Salvatore, Serena
    EYE, 2024, 38 : 162 - 163
  • [8] Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
    Ng, Benjamin
    Kolli, Hema
    Kumar, Naduviledeth Ajith
    Azzopardi, Matthew
    Logeswaran, Abison
    Buensalido, Julius
    Mushtaq, Bushra
    Chavan, Randhir
    Chong, Yu Jeat
    LIFE-BASEL, 2024, 14 (02):
  • [9] Real-World Weekly Efficacy Analysis of Faricimab in Patients with Age-Related Macular Degeneration
    Muth, Daniel R.
    Fasler, Katrin F.
    Kvanta, Anders
    Rejdak, Magdalena
    Blaser, Frank
    Zweifel, Sandrine A.
    BIOENGINEERING-BASEL, 2024, 11 (05):
  • [10] Real -world experience using intravitreal Faricimab for previously treated neovascular age -related macular degeneration
    Ngo, Taylor
    Hang, Abraham
    Virk, Jaipreet
    Moussa, Kareem
    Moshiri, Ala
    Naeini, Parisa Emami
    Yiu, Glenn
    Park, Susanna S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345